Sense Biodetection raises $50m Series B funding

Oxbridge BioMedTech business Sense Biodetection has raised $50 million in a Series B round led by Koch Disruptive Technologies – a subsidiary of £115 billion turnover US giant Koch Industries, Inc, based in Wichita, Kansas. The Series B also included participation from Sense’s existing investors Cambridge Innovation Capital, Earlybird Health, Cambridge entrepreneur Jonathan Milner and […]

Sense Biodetection Raises $50M in Series B Financing toward COVID-19 Test, Dx Portfolio

Sense Biodetection has completed a $50 million Series B financing, with the molecular diagnostics company saying it will use the proceeds to accelerate the launch of its Veros COVID-19 test, and further develop a portfolio of instrument-free, rapid molecular tests. Those tests will be based on Sense’s Veros platform, which is designed to detect a […]

Molecular diagnostics firm raises $50m investment for COVID-19 test

The Veros platform introduces novel and proprietary rapid molecular amplification technology to detect a variety of deadly and costly diseases. The Series B round was led by Koch Disruptive Technologies (KDT), a subsidiary of Koch Industries, Inc. Harry Lamble, CEO of Sense, said: “This Series B round is crucial in providing us with the resources to […]

Insurtech The Zebra earns its unicorn stripes with $150 million raise

US-based insurance comparison platform The Zebra has secured a $150 million Series D funding round, making it the latest fintech unicorn, per TechCrunch. This brings The Zebra’s total funding to date to $261.5 million since its founding in 2012. The fresh capital was raised not to fund operations, but to accelerate growth and new product plans, as […]

The Zebra Becomes A Unicorn With $150M Series D

In the complex world of insurance, The Zebra wants to bring simplicity and transparency. The Austin-based company, which operates an insurance comparison site, raised $150 million in Series D funding, led by an unnamed investor. Joining the round were a group of investors, including Weatherford Capital, as well as Accel, which led the company’s $38.5 million Series C last year. The […]

Austin’s newest unicorn: The Zebra raises $150M after doubling revenue in 2020

The Zebra, an Austin-based company that operates an insurance comparison site, has raised $150 million in a Series D round that propels it into unicorn territory. Both the round size and valuation are a substantial bump from the $38.5 million Series C that Austin-based The Zebra raised in February of 2020. (The company would not […]

Nano Dimension Closes the Acquisition of Machine Learning/Deep Learning Leader, DeepCube Ltd.

Sunrise, Florida, April 23, 2021 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM), an industry leading Additively Manufactured Electronics (AME)/PE (3D-Printed Electronics) provider, announced today that is has closed the previously announced acquisition of DeepCube Ltd. (“DeepCube”) (https://www.deepcube.com), a world leader in Machine Learning/Deep Learning (ML/DL) technology. Nano Dimension paid the shareholders of DeepCube approximately […]

DRUG DEVELOPMENT COMPANY SNAGS $110M FROM KOCH

A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies. Valo Health LLC said in a press release that the investment from the division of Wichita-based Koch Industries Inc. closed its Series B at $300 million pushed its total […]

COULD VALO HEALTH BECOME ONE OF FLAGSHIP PIONEERING’S BIGGEST COMPANIES YET?

The investment firm Flagship Pioneering has incubated a lot of life sciences companies since it was founded in 2000. In fact, while a general partner with Flagship Pioneering over the last 15 years, David Berry has started more than 30 companies, five of which trade publicly right now: Seres Therapeutics, Sensen Bio, Evelo Biosciences, T2 Biosystems and […]

VALO HEALTH GRABS $110M TOP-UP, BRINGING SERIES B TO $300M

Valo Health launched in September with $100 million and a couple of acquisitions under its belt to transform drug development and trim years off R&D timelines. Now, it’s topping up its coffers with $110 million from Koch Disruptive Technologies that will bankroll the development of its technology as well as the discovery and development of […]